• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550250-15
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Angina (1710)
Event Date 07/09/2021
Event Type  Injury  
Event Description
Patient id: (b)(6).It was reported that the procedure was performed on (b)(6) 2020, treating lesions in the mid right coronary artery (rca) and in the proximal left anterior descending (lad) artery.A 2.5 x 15 mm xience sierra stent was implanted in the rca and a 3.5 x 38 mm xience sierra stent was implanted in the lad.On (b)(6) 2021, the patient presented to the emergency department with chest pain, relieved with nitroglycerin.A coronary artery bypass graft (cabg) procedure was performed.Post procedure, the patient remained on intra-aortic balloon pump (iabp) for low ejection fraction.The patient was discharged to home on (b)(6) 2021.No additional information was provided.
 
Manufacturer Narrative
The stent remains in the patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
The stent remains in the patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Patient id: (b)(6).It was reported that the procedure was performed on (b)(6) 2020, treating lesions in the mid right coronary artery (rca) and in the proximal left anterior descending (lad) artery.A 2.5 x 15 mm xience sierra stent was implanted in the rca and a 3.5 x 38 mm xience sierra stent was implanted in the lad.On (b)(6) 2021, the patient presented to the emergency department with chest pain, relieved with nitroglycerin.A coronary artery bypass graft (cabg) procedure was performed.Post procedure, the patient remained on intra-aortic balloon pump (iabp) for low ejection fraction.The patient was discharged to home on (b)(6) 2021.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of angina is listed in the xience sierra, everolimus eluting coronary stent system (eecss), electronic instructions for use (eifu) as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined; however, the reported treatments appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12913287
MDR Text Key285224868
Report Number2024168-2021-10950
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227097
UDI-Public08717648227097
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/14/2021
Device Model Number1550250-15
Device Catalogue Number1550250-15
Device Lot Number0010841
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/28/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/15/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Disability;
Patient Age53 YR
Patient SexMale
Patient Weight80 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-